Patents Assigned to Laboratori Guidotti S.p.A.
  • Pediatric oral liquid compositions containing nepadutant
    Patent number: 9421268
    Abstract: Oral liquid pharmaceutical compositions containing as active ingredient Nepadutant, PGS as solubilizer and optionally a chelating agent. Such compositions are found to be very stable and suitable for paediatric use in the treatment of gastro-intestinal diseases.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: August 23, 2016
    Assignee: LABORATORI GUIDOTTI S.P.A.
    Inventors: Claudia Lewerenz, Reinhard Schmitz, Maria Altamura
  • PEDIATRIC ORAL LIQUID COMPOSITIONS CONTAINING NEPADUTANT
    Publication number: 20150165034
    Abstract: Oral liquid pharmaceutical compositions containing as active ingredient Nepadutant, PGS as solubilizer and optionally a chelating agent. Such compositions are found to be very stable and suitable for paediatric use in the treatment of gastro-intestinal diseases.
    Type: Application
    Filed: July 12, 2013
    Publication date: June 18, 2015
    Applicant: LABORATORI GUIDOTTI S.P.A.
    Inventors: Claudia Lewerenz, Reinhard Schmitz, Maria Altamura
  • Pharmaceutical compositions based on NK2 antagonists for pediatric use
    Patent number: 7727955
    Abstract: Pharmaceutical compositions containing NK2 antagonists are described, useful for the treatment of infantile colics.
    Type: Grant
    Filed: October 26, 2005
    Date of Patent: June 1, 2010
    Assignee: Laboratori Guidotti S.p.A.
    Inventors: Alberto Aleotti, Maria Altamura, Carlo Alberto Maggi
  • Pharmaceutical Compositions Based on Nk2 Antagonists for Pediatric Use
    Publication number: 20080090795
    Abstract: Pharmaceutical compositions containing NK2 antagonists are described, useful for the treatment of infantile colics.
    Type: Application
    Filed: October 26, 2005
    Publication date: April 17, 2008
    Applicant: LABORATORI GUIDOTTI S.P.A.
    Inventors: Alberto Aleotti, Maria Altamura, Carlo Maggi
  • Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
    Patent number: 5731285
    Abstract: Tachyikinin antagonist compounds of the general formula: ##STR1## are described where: X1, X2, X3, X4, X5, and X6 are identical or different and are --NR'--CO-- or --CO--NR"--, where R' is H or C.sub.1-3 alkyl;Y is --CONR--, --NRCO--, OCO, --COO--, --CH.sub.2 --NR--, --NR--CH.sub.2 --, --SS--, --CH.sub.2 --CH.sub.2 --, cis or trans --CH.dbd.CH-- where R is H or C.sub.1-3 alkyl;R1, R2, R3, and R4 are each a hydrophobic group;n and m are identical or different and are each a whole number from 1 to 4. The preparation and pharmaceutical compositions of the compounds are also disclosed.
    Type: Grant
    Filed: October 17, 1996
    Date of Patent: March 24, 1998
    Assignees: A. Menatini Industrie Farmaceutiche, Laboratori Guidotti S.p.A., Malesci-Istituto Farmacobiologico S.p.A.
    Inventors: Vincenzo Pavone, Angelina Lombardi, Carlo Pedone, Carlo Alberto Maggi, Laura Quartara
  • Phenothiazine compounds with anti-bronchospastic activity and pharmaceutical compositions containing them
    Patent number: 4603132
    Abstract: Quarternized derivatives of mequitazine, particularly 3-(10-H-phenothiazine-methyl)-1-methyl-1-azoniabicyclo [2.2.2]-octane iodide, show powerful anti-bronchospastic activity if administered by inhalation.
    Type: Grant
    Filed: March 11, 1985
    Date of Patent: July 29, 1986
    Assignee: Laboratori Guidotti S.p.A.
    Inventor: Alessandro Subissi